OBJECTIVES: Upon completion of this activity, the participant should be able to:   

1. Integrate current evidence-based research into routine hematologic oncology care.

2. Discuss common cases to highlight strides that have been made in treatment using state of the art therapy.

3. Apply patient-centered approaches to improve outcomes in hematologic cancer management.

4. Identify and apply key updates from the latest NCCN Guidelines to support evidence-based clinical decision-making.

PLANNER/MODERATOR DISCLOSURE:  John Smith, MD, has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  Micah Burch, MD, is a consultant for Janssen Pharmaceuticals.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For information, please contact Amahra Browne at [email protected]